Dr. Porcalla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1129 Hale Rd
Memphis, TN 38116Phone+1 901-396-0390Fax+1 901-396-8151
Education & Training
- Children's National Hospital/George Washington UniversityFellowship, Pediatric Infectious Diseases, 1999 - 2002
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1996 - 1999
- Sinai Hospital of BaltimoreInternship, Transitional Year, 1995 - 1996
- University of the Philippines College of MedicineClass of 1994
Certifications & Licensure
- MS State Medical License 2002 - 2025
Publications & Presentations
PubMed
- 3 citationsA Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity.Negar Alami, David C Carter, Nisha V Kwatra, Weihan Zhao, Linda Snodgrass
Plos Neglected Tropical Diseases. 2023-07-01 - 9 citationsExtrapolation as a Default Strategy in Pediatric Drug Development.Margaret Gamalo, Christina Bucci-Rechtweg, Robert M Nelson, Linh Vanh, Ariel Porcalla
Therapeutic Innovation & Regulatory Science. 2022-11-01 - 59 citationsReal-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysisPietro Lampertico, José A. Carrión, Michael P. Curry, Juan Turnes, Markus Cornberg
Journal of Hepatology. 2020-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: